XML 31 R18.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Stockholders' Equity | 6 Months Ended
--- | ---
Jun. 30, 2018
Stockholders' Equity [Abstract] |
Stockholders' Equity | Note 10. Stockholders’ Equity ﻿ The Company’s authorized capital stock consists of 400,000,000 shares of common stock, $0.01 par value per share, and 100,000,000 shares of preferred stock, $0.01 par value per share. T he Company ha s an at-the-market equity offering program (the “$250 Million ATM Program”) pu rsuant to which the Company may issue and sell shares of its common stock having an aggregate offering price of up to $250.0 million ($230.8 million remaining as of June 30, 2018) in amounts and at times to be determined by the Company from time to time. Prior to the implementation of the $250 Million ATM Program, the Company had a $200.0 million ATM program (the “$200 Million ATM Program”), which was substantially utilized as of June 30, 2018 and which is no longer active, and a $150.0 million ATM program (the “$150 Million ATM Program”), which was fully utilized as of June 30, 2017. Actual sales under the $250 Million ATM Program, if any, will depend on a variety of factors to be determined by the Company from time to time, including, among others, market conditions, the trading price of the Company’s common stock, determinations by the Company of the appropriate sources of funding for the Company and potential uses of funding available to the Company. The Company intends to use the net proceeds from the offering of the shares under the $2 5 0 Million ATM Program, if any, for general corporate purposes, which may include future acquisitions and repayment of indebtedness, including borrowings under the Facility. During the three and six months ended June 30, 2018, the Company issued an aggregate of 2,826,167 and 2,885,401 shares, respectively, of common stock at a weighted average offering price of $37.48 and $37.43 per share, respectively, under the $250 Million ATM Program and the $200 Million ATM Program, resulting in net proceeds of approximately $104.4 million and $106.4 million, respectively, and paying total compensation to the applicable sales agents of approximately $1.5 million and $1.6 million, respectively. During the three and six months ended June 30, 2017, the Company issued an aggregate of 2,788,986 and 4,836,086 shares, respectively, of common stock at a weighted average offering price of $32.05 and $30.06 per share, respectively, under the $150 Million ATM Program, resulting in net proceeds of approximately $88.1 million and $143.3 million, respectively, and paying total compensation to the applicable sales agents of approximately $1.3 million and $2.1 million, respectively. ﻿ The Company has a share repurchase program authorizing the Company to repurchase up to 2,000,000 shares of its outstanding common stock from time to time through December 31, 2018. Purchases made pursuant to the program will be made in either the open market or in privately negotiated transactions as permitted by federal securities laws and other legal requirements. The timing, manner, price and amount of any repurchases will be determined by the Company in its discretion and will be subject to economic and market conditions, stock price, applicable legal requirements and other factors. The program may be suspended or discontinued at any time. As of June 30, 201 8, the Company has no t repurchased any shares of stock pursuant to its share repurchase authorization. ﻿ In connection with the A nnual M eeting of s tockholders on May 1, 2018, the Company granted a total of 9,656 shares of unrestricted common stock to its independent directors under the Company’s Amended and Restated 2010 Equity Incentive Plan (the “Plan”) with a grant date fair value per share of $37.29. The grant date fair value of the unrestricted common stock was determined using the closing price of the Company’s common stock on the date of the grant. The Company recognized approximately $0.4 million in compensation costs for both the three and six months ended June 30, 201 8 related to this issuance. ﻿ On July 19, 2017, the Company redeemed all 1,840,000 outstanding shares of the 7.75% Series A Cumulative Redeemable Preferred Stock (“Series A Preferred Stock”) for cash at a redemption price of $25.00 per share, plus an amount per share of $0.096875 representing all accrued and unpaid dividends per share from July 1, 2017 to, but excluding, July 19, 2017. As of both June 30, 2018 and December 31, 2017, no shares of Series A Preferred Stock were issued and outstanding. ﻿ As of June 30, 2018, there were 1,705,000 shares of common stock authorized for issuance as restricted stock grants, unrestricted stock awards or Performance Share awards under the Plan, of which 362,402 were remaining available for issuance. The grant date fair value per share of restricted stock awards issued during the period from February 16, 2010 (commencement of operations) to June 30, 2018 ranged from $14.20 to $32.10. The fair value of the restricted stock that was granted during the six months ended June 30, 2018 was approximately $0.9 million and the vesting period for the restricted stock is five years. As of June 30, 2018, the Company had approximately $4.6 million of total unrecognized compensation costs related to restricted stock issuances, which is expected to be recognized over a remaining weighted average period of approximately 2.7 years. The Company recognized compensation costs of approximately $0.4 million and $0.5 million for the three months ended June 30, 2018 and 2017, respectively, and approximately $0.9 million for both the six months ended June 30, 2018 and 2017 related to the restricted stock issuances. ﻿ The following is a summary of the total restricted shares granted to the Company’s executive officers and employees with the related weighted average grant date fair value share prices for the six months ended June 30, 2018: ﻿ Restricted Stock Activity:
﻿ |  |  |  |  |
﻿ |  |  |  |  |
﻿ |  | Shares |  |  | Weighted Average Grant Date Fair Value
﻿Non-vested shares outstanding as of December 31, 2017 |  | 357,183 |  | $ | 21.01
﻿Granted |  | 27,003 |  |  | 32.10
﻿Forfeited |  | (11,830) |  |  | 20.30
﻿Vested |  | (15,338) |  |  | 20.21
﻿Non-vested shares outstanding as of June 30, 2018 |  | 357,018 |  | $ | 21.91
﻿ The following is a vesting schedule of the total non-vested shares of restricted stock outstanding as of June 30, 2018: ﻿
﻿ |  |
﻿ |  |
﻿Non-vested Shares Vesting Schedule |  | Number of Shares
﻿2018 (6 months) |  | -
﻿2019 |  | 24,372
﻿2020 |  | 303,433
﻿2021 |  | 13,750
﻿2022 |  | 10,068
﻿Thereafter |  | 5,395
﻿Total Non-vested Shares |  | 357,018
﻿ Long-Term Incentive Plan: ﻿ As of June 30, 2018, there are three open performance measurement periods for the Performance Share awards: January 1, 201 6 to December 31, 201 8, January 1, 201 7 to December 31, 201 9 and January 1, 201 8 to December 31, 20 20. During the six mont hs ended June 30, 201 8, the Company issued 195,963 shares of common stock at a price of $34.50 per share related to the Performance Share awards for the performance period from January 1, 2015 to December 31, 201 7. The expense related to the open Performance Share awards varies quarter to quarter based on the Company’s relative share price performance. ﻿ The following table summarizes certain information with respect to the Performance Share awards (dollars in thousands): ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  | Expense |  | Expense
﻿ |  |  | Fair Value |  |  | Accrual |  | For the Three Months Ended June 30, |  | For the Six Months Ended June 30,
﻿Performance Share Period |  |  | June 30, 2018 |  |  | June 30, 2018 |  |  | 2018 |  |  | 2017 |  |  | 2018 |  |  | 2017
﻿ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
﻿January 1, 2018 - December 31, 2020 |  | $ | 3,168 |  | $ | 523 |  | $ | 279 |  | $ | - |  | $ | 523 |  | $ | -
﻿January 1, 2017 - December 31, 2019 |  |  | 5,298 |  |  | 2,642 |  |  | 509 |  |  | 470 |  |  | 1,109 |  |  | 675
﻿January 1, 2016 - December 31, 2018 |  |  | 5,821 |  |  | 4,844 |  |  | 579 |  |  | 1,046 |  |  | 1,393 |  |  | 1,355
﻿January 1, 2015 - December 31, 2017 |  |  | - |  |  | - |  |  | - |  |  | 996 |  |  | - |  |  | 1,603
﻿Total |  | $ | 14,287 |  | $ | 8,009 |  | $ | 1,367 |  | $ | 2,512 |  | $ | 3,025 |  | $ | 3,633
﻿ Dividends: ﻿ The following table sets forth the cash dividends paid or pa yable per share during the six months ended June 30, 2018: ﻿
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿ |  |  |  |  |  |  |  |  |  |  |
﻿For the Three Months Ended |  | Security |  | Dividend per Share |  | Declaration Date |  | Record Date |  | Date Paid
﻿ March 31, 2018 |  | Common stock |  | $ | 0.22 |  | February 6, 2018 |  | March 28, 2018 |  | April 12, 2018
﻿ June 30, 2018 |  | Common stock |  | $ | 0.22 |  | May 1, 2018 |  | July 6, 2018 |  | July 20, 2018
﻿

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_StockholdersEquityNoteDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration